• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Type I and type II Helicobacter pylori infection status and their impact on gastrin and pepsinogen level in a gastric cancer prevalent area

    2020-08-18 10:00:24LinYuanJunBoZhaoYingLeiZhouYaBinQiQiongYaGuoHaiHuiZhangMuhammadNomanKhanLingLanChangHeJiaYanRuiZhangSongZeDing
    World Journal of Gastroenterology 2020年25期

    Lin Yuan, Jun-Bo Zhao, Ying-Lei Zhou, Ya-Bin Qi Qiong-Ya Guo, Hai-Hui Zhang, Muhammad Noman Khan,Ling Lan, Chang-He Jia, Yan-Rui Zhang, Song-Ze Ding

    Abstract

    Key words: Helicobacter pylori; Chronic gastric diseases; Gastrin-17; Pepsinogen; Gastric cancer

    INTRODUCTION

    Helicobacter pylori(H. pylori) infection is the major cause of chronic gastritis, peptic ulcers, gastric cancer and mucosa-associated lymphoid tissue lymphoma, it is also associated with many extra gastrointestinal diseases[1-3].H. pyloricytotoxin CagA and VacA are major virulence factors and molecular basis for disease pathogenesis.H. pyloristrains that carrycagPAI with CagA-, VacA-positive cause severe gastric inflammation, which contributes to either tissue damage or neoplastic transformation, are high-risk strains of gastric cancer, and the role of CagA protein is critical in these processes[4]. Studies have shown that there is both genotypic and geographic diversity ofH. pyloriinfection, which can trigger different inflammatory processes and result in various degrees of pathological consequences[4-6].

    Type IH. pyloriexpresses CagA and VacA protein; type II strain does not express CagA and VacA[7]. CagA-, VacA-positive strains are the major forms ofH. pyloriinfection in many areas globally, corresponding to their high prevalence in precancerous lesions and gastric cancer incidences[4]. However, their infection status and roles in the stepwise gastric disease progression in this high gastric cancer prevalent area has not been studied[8].

    Serological detection of pepsinogen (PG) I, II, PG I/PG II ratio and gastrin-17 (G-17) provide valuable information on the status of gastric mucosa, and they have been used as epidemiological markers for gastric cancer risk investigation[9-12]. Studies have indicated that low concentrations of PG I and PG I/PG II ratios are indicators of gastric atrophy, which are linked with elevated gastric cancer risk[9,10]. However, others have indicated that the results are not consistent and not sensitive enough to replace endoscopy[11,12]. PG I/PG II ratio also should not be used as a biomarker of gastric neoplasia as recommended[1]. It is therefore uncertain if they might be suitable to evaluate stepwise gastric disease progression and development of mucosal precancerous conditions in the presence or absence ofH. pyloriinfection in clinical practice.

    In the present study, we investigated the prevalence of type I and type IIH. pyloriinfection in stepwise chronic gastric diseases and the clinical implications. Their impact on G-17 and PGs levels was also evaluated. The results indicated that there is a stepwise increase in type IH. pyloriinfection rate as disease progress from chronic gastritis to gastric cancer. Both types ofH. pyloriinduce an increase in G-17 level, while type IH. pyloriis the major strains that affects PG I, PG II levels and PG I/PG II ratio in chronic gastric diseases in this geographic region. The results provide insight on the subtypes ofH. pyloriinfection status and their impact on G-17 and PGs, which will be helpful to guideH. pylorieradication and application of G-17 and PGs assay in clinical practice.

    MATERIALS AND METHODS

    Study population

    This cross-section study was conducted at the Department of Gastroenterology, People’s Hospital of Zhengzhou University, Zhengzhou, Henan, China. From March 2018 to March 2019, a total of 3572 consecutively ward admitted patients with upper gastrointestinal symptoms were examined. Exclusion criteria were as follows: (1) Taking proton pump inhibitors, bismuth salts, H2-receptor blockers or other medications that could affect test results over the past 2 wk, taking antibiotics over the past 1 mo; (2) Severe concomitant diseases such as liver, kidney, nervous system or cardiac dysfunction; (3) People with active upper gastrointestinal bleeding; (4) Patients with a history of gastrointestinal surgery for gastric cancer, esophageal cancer or gastric adenoma; and (5) People with mental illness or severe neurosis, affecting correct expression or study. The study finally enrolled 523 patients, the flow chart of patient screening is summarized in Figure 1.

    All 523 enrolled patients were examined by upper-endoscopy to get pathological confirmation. Based on histopathologic types, subjects were categorized into five groups: Non-atrophic gastritis (NAG), non-atrophic gastritis with erosion (NAGE), chronic atrophic gastritis (CAG), peptic ulcers (PU) and gastric cancer (GC). Demographic data of patients including age and gender were recorded, andH. pyloriCagA, VacA status, G-17, PG I, II levels and PG I/PG II ratio were analyzed. The research protocol was approved by the Ethics Committee of People’s Hospital of Zhengzhou University (2019-KY-No. 10); informed consents were obtained from all participating patients.

    Measurement of H. pylori infection

    The status ofH. pyloriinfection was confirmed by both13C-urea breath test (UBT) and serologicalH. pyloriantibody test, patients were considered not infected when both tests were negative; when patients were either13C-UBT or serologicalH. pyloriantibody positive, but not both, they were not enrolled to avoid false-positive or -negative results.13C-UBT was performed after overnight fasting, a baseline breath sample was obtained by blowing gas into a bag container, and a powder capsule containing 50 mg of13C-urea was given to patients with 80-100 mL water. The second breath sample was collected after 30 min of meditation. Patients were consideredH. pyloripositive if the difference between baseline sample and 30-min sample exceeded 4.0 arbitrary units by13C-breath test (HY-IREXC 16 channel; Huayou Mingkang Photoelectric Technology Co., Ltd, Guangzhou, China).

    Figure 1 Flowchart of enrolled patients–screening program.H. pylori: Helicobacter pylori.

    Serological measurements of H. pylori antibody, G-17 and PGs

    Five milliliters of fasting venous blood sample was collected from each participant. All samples were centrifuged at 1500 ×gfor 5 min and analyzed within 2 h of blood collection. Serum anti-H. pyloriantibody, G-17, PG I, PG II levels, and PG I/PG II ratio were measured by enzyme-linked immunosorbent assay (ELISA) kit (Helicobacter pyloriELISA kit, Blot Biotech Co., Ltd, Shenzhen, China; PG I, PG II, G-17 ELISA kits, Biohit Biotechnology Co., Ltd. Anhui, China). The procedure followed manufacturers’ instructions; quality control analysis showed that the coefficient of variation in intrabatch and inter-batch sample tests was less than 10%.

    Determination ofH. pyloripositivity from blood samples: (1) Type IH. pyloriantibody positive: either or both CagA and VacA bands were present; (2) Type IIH. pyloriantibody positive: only one of urease (Ure) A and UreB bands or both appeared, no CagA, VacA bands were present; and (3)H. pyloriantibody negative: Only control band appeared in the color-developing zone, and no positive zone was observed. RepresentativeH. pyloriserological test blot pictures are provided in Supplementary Figure 1.

    Endoscopic and histopathological evaluation

    Histopathological diagnosis was available in all enrolled 523 patients. Two pieces of biopsy specimen were obtained from the lesion area, antrum and angulus during endoscopic examination. The biopsies were oriented, fixed in formalin, embedded in paraffin blocks and then sectioned and stained with hematoxylin and eosin for histopathological analysis. For histologic sections where there was initial disagreement on histopathologic interpretation, the final results were determined through adjudication among two pathologists and a third pathologist.

    Statistical analysis

    Data were analyzed using SPSS for Windows Version 22 (Armonk, NY, United States). Continuous variables were described as mean ± standard deviation, while categorical variables were described as percentages or frequencies. All data were tested for normal distribution by Kolmogorov-Smirnov test and homogeneity of variances by Levene’s test. Data of normal distribution and similar variances were tested by Student’s “t” test for two independent samples comparison, and analysis of variance for multiple comparisons among different groups. A comparison of ratios was made by theχ2test. APvalue less than 0.05 was considered statistically significant, which was derived from two-tailed tests. Receiver operating characteristic (ROC) curves were used to calculate the overall diagnostic performance of G-17, PG I, PG II, and PG I/PG II ratio in PU, CAG and GC patients to determine the best cutoff values, sensitivity and specificity.

    RESULTS

    Overall H. pylori infection status of patients

    H. pyloriinfection status of 3572 patients is presented in Figure 1. Among which, 2714 (76.0%) patients were positive either by UBT test, serological test or both, and 858 (24.0%) patients were negative. AmongH. pylori-positive patients, 1226 were excluded due to either surgery, medication or bleeding reasons, and 1086 patients were excluded due to either only13C-BUT or serum antibody test positive but not both; the final enrolled patient number was 402 with both tests being positive. In 858H. pylorinegative patients, 737 patients were excluded either due to bleeding, surgery or severe organ diseases; this resulted in only 121 patients being enrolled with both tests being negative. Interestingly, we noticed almost identicalH. pyloriinfection rates when comparing the prior- and post-excluded non-enrolled patients. The infection rates of the final enrolled patients were 76.9% positive and 23.1% negative (Figure 1).

    Patient clinical data and H. pylori infection status

    Among the 523 enrolled patients, 305 were male and 218 were female, with an average age of 53.4 ± 11.6 years (range from 28 to 79). Their clinical characteristics andH. pyloriinfection status are presented in Table 1. Patients in 51-60 and 61-80 years age groups had the highestH. pyloriinfection rates of 78.5% (150/191) and 78.4% (116/148), respectively. The average age of patients in the GC group was significantly higher than that in NAG, NAGE and PU groups (P< 0.05). The mean age of the CAG group was higher than that in the NAG group (P< 0.001). There was no significant difference inH. pyloriinfection status between male and female gender.H. pyloriinfection in male and female genders were mainly type IH. pyloristrains (54.8%, 56.9% respectively), which were significantly higher than that of type II andH. pylorinegative patient groups (range from 20.2%-23.3%). There was a significant male dominance in CAG, PU and GC groups (P< 0.05). Among 77 CAG patients, 48 (62.3%) patients were antrum atrophic gastritis and 29 (33.8%) were corpus atrophic gastritis, and all 43 gastric cancer patients were intestinal type.

    Prevalence of Type I and Type II H. pylori infection in stepwise chronic gastric diseases

    TotalH. pyloriinfection rate of 523 patients was 76.9% (402/523), of which type IH. pyloriinfection rate was 72.4% (291/402), and type II infection rate was 27.6% (111/402). Overall, 88.4% of GC patients wereH. pyloripositive, and 84.2% of them were type I infection, only 11.6% of GC wereH. pylorinegative. As the disease progressed,H. pyloriinfection rate was gradually increased in NAG, NAGE, PU, CAG and GC groups; among whichH. pylori-positive rate reached the highest level in PU group, accounting for 90.4% (85/94) of the patients. Infection rates of type IH. pyloriin NAG, NAGE, PU, CAG and GC groups were 67.9%, 62.7%, 77.6%, 79.7%, 84.2%, respectively; and was significantly higher than the corresponding type IIH. pylorigroups; and type IH. pyloriinfection rates were also higher in PU, CAG, and GC groups when compared with the NAG group (Table 2).

    Table 1 Patient clinical data and Helicobacter pylori infection status

    Table 2 Infection rates of type I and type II Helicobacter pylori in stepwise chronic gastric diseases

    Distribution of H. pylori CagA, VacA, UreA and UreB in stepwise chronic gastric diseases

    Positive rates of CagA, VacA, UreA and UreB antibodies are described in Table 3. In 402 infected samples, the percentage of CagA, VacA, UreA and UreB were 70.1%, 61.9%, 70.6% and 98.8%, respectively. CagA antibody was detected in 63.3%, 60.0%, 76.5%, 79.7% and 84.2% in NAG, NAGE, PU, CAG and GC groups, respectively. The positive rates of CagA and VacA were highest in GC group and lowest in NAGE group. UreB antibodies were present in 98.8% of patients withH. pyloriinfection, and there was no statistical differences between disease groups (P> 0.05).

    Effects of H. pylori infection on overall G-17, PG I, PG II levels and PG I/PG II ratio

    Overall serum G-17, PG I, PG II values and PG I/PG II ratio at differentH. pyloriinfection status are shown in Table 4. G-17 and PG II values inH. pyloriinfectedgroups were significantly higher and PG I/PG II ratio were lower than those inH. pylori-negative patients(P< 0.05); while PG I level was not different betweenH. pyloripositive and -negative groups (P> 0.05). There was also no significant difference in PG I levels between type I and IIH. pylori-infected patients. G-17 and PG II levels were significantly increased and PG I/PG II ratio were decreased only in patients with type IH. pyloriinfection when compared with type II andH. pylori-negative patients (P< 0.05).

    Table 3 Distribution of CagA, VacA, UreA and UreB serological antibodies in stepwise chronic gastric disease

    Table 4 Effects of Helicobacter pylori infection on gastric gastrin-17, pepsinogen I, pepsinogen II levels and pepsinogen I/II ratios

    Receiver operating characteristic curves for G-17, PG I, PG II and PG I / PG II in the prediction of CAG, PU and GC patients

    Figure 2 shows ROC curves for G-17, PG I, PG II and PG I/PG II in the prediction of CAG, PU and GC patients. ROC curves for predicting PU based on G-17, PG I, PG II and PG I/PG II ratio are listed in Figure 2 a1-2. Area under the receiver operating characteristic curves (AUROC) were 0.579 (95%confidence interval (CI): 0.514-0.643), 0.663 (95%CI: 0.599-0.729) and 0.653 (95%CI: 0.593-0.713), and 0.529 (95%CI: 0.460-0.598); cut-off values of Youden index were 5.91 pmol/L, 146.20 μg/L, 13.31 μg/L and 9.49, respectively; the sensitivity was 45.7%, 52.1%, 62.8% and 55.3%, respectively; and specificity was 69.4%, 76.9%, 64.5% and 54.0%, respectively.

    ROC curves for predicting CAG based on G-17, PG I, PG II and PG I/PG II ratio are listed in Figure 2 b1-2. AUROC were 0.550 (95%CI: 0.474-0.626), 0.531 (95%CI: 0.455-0.607), 0.610 (95%CI: 0.535-0.684) and 0.623 (95%CI: 0.552-0.694), respectively; the cutoff values of Youden index were 4.63 pmol/L, 110.7 μg/L, 7.41 μg/L and 9.37, respectively; the sensitivity was 71.4%, 68.8%, 50.5% and 68.8%, respectively; and specificity was 39.4%, 46.0%, 70.9% and 49.8%, respectively.

    ROC curves for predicting GC based on G-17, PG I, PG II and PG I/PG II ratio are listed in Figure 2 c1-2, AUROC were 0.786 (95%CI: 0.737-0.834), 0.634 (95%CI: 0.533-0.735), 0.719 (95%CI: 0.646-0.792) and 0.760 (95%CI: 0.684-0.836), respectively; cut-off values of Youden index: 6.21pmol/L, 174.49 μg/L, 14.83 μg/L and 6.47, respectively; the sensitivity was 88.4%, 53.5%, 68.8% and 67.4%, respectively; and specificity was 68.3%, 81.0%, 64.4% and 72.7%, respectively.

    Figure 2 Receiver operating characteristic curves for gastrin-17, pepsinogen I, pepsinogen II and pepsinogen I / pepsinogen II in prediction of chronic atrophic gastritis, peptic ulcers and gastric cancer patients. Receiver operating characteristic (ROC) curves of gastrin-17 (G-17), pepsinogen (PG) I, PG II level and PG I/PG II ratio in predicting chronic atrophic gastritis (CAG), peptic ulcers (PU) and gastric cancer (GC) patients. a1-2: ROC curves of PG I/PG II ratio, G-17, PG I and PG II values for predicting PU; b1-2: ROC of PG I/PG II ratio, G-17, PG I and PG II values for predicting CAG; c1-2: ROC of PG I/PG II ratio, G-17, PG I and PG II values for predicting GC. PG: Pepsinogen; PU: Peptic ulcers; AUROC: Area under receiver operating characteristic curve; CAG: Chronic atrophic gastritis; G-17: Gastrin-17; GC: Gastric cancer.

    Effects of type I and type II H. pylori infection on G-17, PG I, PG II levels and PG I/PG II ratio in gastric diseases

    Table 5 shows the stratified disease group analysis results. G-17 levels in NAG, NAGE and GC groups inH. pylori-infected patients were significantly higher than that ofH. pylori-negative patients (P< 0.05), and this effect was mostly from type I infection, as type IIH. pyloriinfection andH. pylori-negative group did not show a difference acrossdisease groups. In PU patients, the level of G-17 in type IH. pylori-positive patients was significantly higher than that in type IIH. pylori-infected patients (P<0.05). G-17 levels in the GC group were significantly higher when compared with NAG, NAGE and CAG groups in bothH. pylori- and type IH. pylori-infected patients.

    Table 5 Effects of Helicobacter pylori infection on gastric gastrin 17, pepsinogens levels in stepwise chronic gastric diseases

    PG I levels in type IIH. pylori-positive andH. pylori-negative patients showed no difference among all disease groups, while PG I level in GC group was significantly higher when compared with NAG, NAGE and CAG groups only in both type I andH. pylori-positive patients (P<0.05).

    PG II levels inH. pylori- and type IH. pylori-infected patients were significantly higher in NAG, NAGE, PU and CAG groups when compared withH. pylori-negative patients (P< 0.05) except in the GC group, which showed no difference. PG II levels inH. pylori-negative and type IIH. pylori-infected patients had no difference among all disease groups. InH. pylori-infected patients, PG II level was significantly higher in the GC group than that in NAG, NAGE and CAG groups. PG II level was also higher in the GC group over the CAG group in type IH. pylori-infected patients.

    PG I/PG II ratios ofH. pylori- and type IH. pylori-positive patients were lower when compared withH. pylori-negative patients in NAG, NAGE and CAG groups (P< 0.05). Except for the CAG group, PG I/PG II ratios in type IIH. pylori-infected groups were not significantly different from those inH. pylori-negative groups (P> 0.05). In type II andH. pylori-negative patients, PG I/PG II ratios showed no difference across different disease groups (P> 0.05); while PG I/PG II ratio of bothH. pylori- and type IH. pyloripositive patients was significantly lower in the GC group when compared with the NAG, NAGE and PU groups (P< 0.05) (Table 5).

    DISCUSSION

    H. pyloricytotoxins CagA and VacA are major virulence factors and pathogenic mechanisms. Virulent strains are associated with increased risk of gastroduodenal disorders, but virulence varied among different strains ofH. pylori[4-6,13]. Clinical relevance of type IH. pyloriinfection in gastric disease and gastric cancer has been very well defined, but the mechanism of type IIH. pylori-induced gastric disease needs further exploration. The present results have demonstrated that type IH. pyloriis the major form of infection in stepwise gastric diseases in present region, which is a high gastric cancer risk area[8].

    Meta-analyses[4,14]have shown that CagA seropositivity are correlated with the occurrence of gastric cancer amongH. pylori-infected patients. Sheikhet al[15]examined 201 patients infected byH. pyloriand found thatcagA gene was detected in 66.7% of the isolates; positive rates ofcagAgene in gastric cancer and peptic ulcer patients were 68.2% and 71%, respectively. Kimet al[16]found thatH. pyloriinfection in South Koreans was closely related to highly virulent strains [vacA s1/i1/m1, cagA(+),iceA1(+),and oipA(+)] and has an intimate association with the progression of peptic ulcer diseases. A recent survey of the high gastric cancer incidence area in Shandong Province, China showed[17]that seroprevalences of CagA, VacA antibodies in 573H. pylori-infected patients were 83.9%, 38.9%, respectively; suggesting that CagA-positive strains are the dominant form of infection in Chinese population and are associated with progression of gastric mucosal lesions.

    Here, we noted a high infection rate ofH. pyloriin GC patients, where 88.4% of GC areH. pyloripositive, 84.2% of them are type I infection, and only 11.6% of GC areH. pylorinegative. Such a high rate ofH. pyloriinfection in GC patients has not been reported in this area previously. A Japanese study in 2011 indicated thatH. pylorinegative gastric cancers are rare in Japan[18], and both intestinal type and diffuse type of gastric cancer are closely related toH. pyloriinfection[19]. The current results are in line with these results, and indicate an important role of type IH. pyloriin the development of upper gastrointestinal diseases and gastric cancer. It is also worth exploring further the mechanism ofH. pylori-negative and type IIH. pylori-infected GC patients.

    PG I is produced by chief cells and mucosal neck cells in the fundic glands, whereas PG II is produced in fundic glands, pyloric glands and Brunner’s glands. Gastric inflammation can lead to increased release of both pepsinogens into the bloodstream, with a greater increase in PG II than in PG I[20]. Other previous studies[8,9,21]have reported that low PG I levels and/or low PG I/PG II ratios are associated with increased risk of gastric cancer. PG I < 70 μg/L and PG I/PG II ratio < 3.0 have been frequently applied as the thresholds for defining population with high-risk of gastric cancer.H. pyloriinfection causes chronic inflammation of gastric mucosa[22]and affects the secretion of PGs and gastrin, but very few studies have explored the different effects of type I and type IIH. pylorion G-17 and PGs levels.

    In this study,H. pylori-positive patients have high levels serum PG II and G-17 and lower levels of PG I/PG II ratio when compared withH. pylori-negative patients. The results are in agreement with previous reports[20,23]. Our study further found that type IH. pyloriinfection result in a significant increase in PG II levels and a marked decline of PG I/PG II ratios when compared with type IIH. pyloriinfection, which is an effect that has not been shown previously. We also noted that PG I levels have no difference inH. pylori-negative and type IIH. pylori-positive patients across different disease groups. PG I levels were significantly increased in GC and PU patients inH. pylori- and type IH. pylori-infected group over the NAG, NAGE and CAG group patients. The results differ from previous reports that found low PG I level is associated with GC risk[24], probably due to different analysis methods or patients population involved. Further research is needed to explore the effect ofH. pylorion PG I level in different gastric diseases.

    Hypergastrinemia is more common in patients withH. pylori-infected gastroduodenal diseases, which may be one cause of precancerous lesions or gastric cancer[25,26]. Gastrin is synthesized and secreted from antral G-cells.H. pylori-associated gastritis tends to raise serum gastrin levels, which is possibly due to hyperplasia of antral G-cells and an acid-suppressive effect of chronic gastritis when the corpus mucosa is involved. Our study shows a significant increase in G-17 inH. pyloripositive patients, which is consistent with previous results[25,26], and we further find that the levels of G-17 in type IH. pyloriinfected patients are significantly higher than that in type IIH. pylori-infected patients (P< 0.05). The response of G-17 toH. pyloriappears to be disease stage dependent, as in PU and CAG patients; there is no difference when compared withH. pylori-negative controls. Further studies are required to elucidate its pathogenesis inH. pylori-induced carcinogenesis.

    In the current study, as the disease progresses, the levels of G-17, PG I, PG II and PG I/PG II ratios do not show differences in allH. pylori-negative and type IIH. pyloripositive groups. In contrast, in type IH. pylori-positive groups, G-17, PG I and PG II levels are significantly higher and PG I/PG II ratios are lower in GC patients when compared with NAG, NAGE and CAG patients. The explanation of the results is probably due to the presence of CagA-, VacA-proteins, which are majorH. pylorivirulence factors that cause greater epithelial injury and mucosal inflammation, including the release of inflammatory mediators or cytokines that affect epithelial cell homeostasis, therefore resulting in disturbed secretion of PGs and gastrin[27,28].

    Application of G-17, PG I, PG II levels and PG I/PG II ratios in gastric cancer epidemiology study have been reported extensively, although their predicative values in stepwise gastric disease in clinical studies have not been very well defined. Previous investigations have generated inconsistent conclusions[9-12], and our results using AUROC analysis (Figure 2) indicated relatively low predictive value range from 0.529-0.786 for PU, CAG and GC patients, and type IH. pyloriinfection is the major factor that affects their levels as the disease progresses. These data provide insight to evaluate their application during clinical practice and are helpful in explaining the results.

    In CAG patients, we also noticed that our PGI level and PG I/PG II ratios are slightly higher when compared with other reports[9-12], and as all the CAG patients have histological confirmation, we therefore consider this effect could be due to patient population- or region-based variations, or might be due to variations from the degrees of atrophy itself. Future studies are required to explain these discrepancies.

    Results of this study also show thatH. pyloriinfection rate in our hospitalized patients is 76.9%, which is higher than that in the general population[1,2]. This could be because all patients enrolled in this study have gastrointestinal symptoms, so the infection rate ofH. pyloriis reasonably higher. One important difference between the current investigation and previous studies is that screening criteria for patients withH. pyloriinfection is more strict, as patients with only both13C-BUT and serologicalH. pyloriantibody positive were enrolled. This selection makes our research results more accurate and reliable, allowing for the true status ofH. pyloriinfection and reducing the possibility of false-positives and -negatives. Moreover, the fact that the proportions ofH. pyloriinfection rates prior- and post-patient selections are almost identical indicates that the data analyses are reliable and not biased.

    In conclusion, the present study evaluated type I and type IIH. pyloriinfection status in chronic gastric disease and their impact on commonly used gastric cancer risk markers, such as PG I and PG II levels and PG I/PG II ratio in this high gastric cancer risk area. We noted thatH. pyloriinfection rate is high in our gastric cancer patients, and only about 11.6% of gastric cancers wereH. pylorinegative. Type IH. pyloriwas the major form of infection. Our results also reveal that the effects ofH. pylorion PG I, PG II and PG I/PG II ratio are mostly from type I strain infection and not from type II strain infection. The data provide insight inH. pylori-induced carcinogenesis and will be helpful to guide clinical practice forH. pylorieradication, to explain G-17 and PGs clinical results and for disease prevention.

    ARTICLE HIGHLIGHTS

    Research objectives

    We investigated the prevalence of type I and type IIH. pyloriinfection in stepwise gastric diseases and the clinical implications; their impact on G-17 and PGs levels during routine clinical practice were also evaluated.

    Research methods

    Five hundred and twenty-three hospital admitted patients were enrolled in this study.H. pyloriinfection was confirmed by both13C-urea breath test and serological assay. Their serological G-17, PG I, PG II values and PG I/PG II ratio were also measured. Receiver operating characteristic curves were used to calculate the overall diagnostic performance of G-17, PG I, PG II and PG I/PG II ratio in peptic ulcers (PU), chronic atrophic gastritis (CAG) and gastric cancer (GC) patients to determine the best cutoff values, sensitivity and specificity.

    Research results

    The infection rate of 523 enrolled patients was 76.9%, among which type IH. pyloriinfection accounted for 72.4%, and type II was 27.6%. Overall, 88.4% of GC patients wereH. pyloripositive, 84.2% of them were type I infection, and only 11.6% of GC patients wereH. pylorinegative.H. pyloriinfection resulted in significantly higher G-17 and PG II values and decreased PG I/PG II ratio. Both types ofH. pyloriinduced higher G-17 level, but type I strain infection resulted in an increased PG II level and decreased PG I/PG II ratio in NAG, NAGE and CAG patients. PG I levels showed no difference among disease groups, and only showed a difference in stratified analysis in GC and PU patients. The diagnostic performance of G-17, PG I, PG II and PG I/PG II ratio in PU, CAG and GC patients indicated relatively low predictive value.

    Research conclusions

    Type IH. pyloriinfection is the major form of infection in this geographic region, and a very low percentage (11.6%) of GC patients are not infected byH. pylori. Both types ofH. pyloriinduce an increased G-17 level, while type IH. pyloriis the major strain that affects PG I, PG II levels and PG I/PG II ratio in stepwise chronic gastric diseases.

    Research perspectives

    The results provide insight onH. pyloriinfection status in hospital admitted patients, and their impact on G-17 and PGs levels, which will be helpful to guideH. pylorieradication and explain G-17 and PGs assay results in clinical practice.

    ACKNOWLEDGEMENTS

    Authors are grateful to the staff of the Department of Gastroenterology and Hepatology, People’s Hospital of Zhengzhou University for their valuable assistance in this work.

    国产精品香港三级国产av潘金莲| 很黄的视频免费| 中出人妻视频一区二区| 真人做人爱边吃奶动态| 国产高清视频在线播放一区| 亚洲熟妇中文字幕五十中出| 免费观看的影片在线观看| 午夜福利成人在线免费观看| 成年版毛片免费区| 一级a爱片免费观看的视频| 国产三级黄色录像| 18禁黄网站禁片午夜丰满| 99热这里只有是精品50| 亚洲精品在线美女| 97超视频在线观看视频| 久久九九热精品免费| 国内久久婷婷六月综合欲色啪| 国产精品99久久久久久久久| 美女大奶头视频| 听说在线观看完整版免费高清| 可以在线观看的亚洲视频| 淫妇啪啪啪对白视频| 国产精品亚洲一级av第二区| 88av欧美| 午夜精品久久久久久毛片777| 国产在线精品亚洲第一网站| 在线观看免费视频日本深夜| 精品乱码久久久久久99久播| 最近在线观看免费完整版| 九色国产91popny在线| 一级黄色大片毛片| 欧美黑人欧美精品刺激| 桃红色精品国产亚洲av| 看免费av毛片| 嫩草影视91久久| 亚洲中文av在线| 国产真实乱freesex| 国内精品久久久久精免费| 一区二区三区激情视频| 久久中文看片网| 亚洲精华国产精华精| 精品99又大又爽又粗少妇毛片 | АⅤ资源中文在线天堂| 亚洲人与动物交配视频| 在线观看舔阴道视频| 亚洲av成人不卡在线观看播放网| 国内毛片毛片毛片毛片毛片| 成人鲁丝片一二三区免费| 中文字幕av在线有码专区| 黄色成人免费大全| 白带黄色成豆腐渣| 日本黄色片子视频| 亚洲av电影不卡..在线观看| 国产成人av激情在线播放| 久久人妻av系列| 国产综合懂色| 99精品在免费线老司机午夜| 人人妻人人看人人澡| 免费在线观看日本一区| 国产亚洲精品av在线| 无限看片的www在线观看| 国产精品一区二区精品视频观看| 亚洲欧美精品综合一区二区三区| 我的老师免费观看完整版| 女人高潮潮喷娇喘18禁视频| 草草在线视频免费看| 亚洲精品美女久久久久99蜜臀| 久久久精品欧美日韩精品| 色播亚洲综合网| 精品一区二区三区视频在线 | 国产成人精品久久二区二区91| 国产成人精品久久二区二区91| 久久午夜亚洲精品久久| 欧美日韩福利视频一区二区| 欧美另类亚洲清纯唯美| 亚洲无线观看免费| 亚洲av成人不卡在线观看播放网| 国产乱人伦免费视频| 国产精品影院久久| 久久亚洲精品不卡| 亚洲av美国av| 老汉色av国产亚洲站长工具| 精品国产乱码久久久久久男人| 中国美女看黄片| bbb黄色大片| 中出人妻视频一区二区| 午夜精品一区二区三区免费看| 韩国av一区二区三区四区| 国产黄片美女视频| 久久久久久人人人人人| 日韩欧美一区二区三区在线观看| 观看美女的网站| 国产淫片久久久久久久久 | 成人永久免费在线观看视频| 精品国产三级普通话版| 久久午夜亚洲精品久久| 一本综合久久免费| 草草在线视频免费看| 性色avwww在线观看| 黄色丝袜av网址大全| 在线观看免费视频日本深夜| 九九热线精品视视频播放| 很黄的视频免费| 又黄又粗又硬又大视频| 免费av毛片视频| 免费观看的影片在线观看| 欧美最黄视频在线播放免费| 村上凉子中文字幕在线| 嫁个100分男人电影在线观看| 高潮久久久久久久久久久不卡| 午夜福利高清视频| 成人午夜高清在线视频| 日本一本二区三区精品| 男女午夜视频在线观看| 亚洲精品久久国产高清桃花| 欧美高清成人免费视频www| 亚洲美女黄片视频| 午夜免费激情av| 天堂网av新在线| 欧美+亚洲+日韩+国产| 国产精品精品国产色婷婷| 免费看日本二区| 亚洲午夜精品一区,二区,三区| 久久99热这里只有精品18| 免费观看的影片在线观看| 99热精品在线国产| 国产真人三级小视频在线观看| 国产伦人伦偷精品视频| 国产成人av教育| 国产人伦9x9x在线观看| 久久精品亚洲精品国产色婷小说| 亚洲va日本ⅴa欧美va伊人久久| 国产亚洲精品久久久久久毛片| 国产高潮美女av| 亚洲欧美日韩无卡精品| 香蕉av资源在线| 亚洲狠狠婷婷综合久久图片| 免费观看的影片在线观看| 国产精品亚洲av一区麻豆| 看片在线看免费视频| 国产精品亚洲一级av第二区| 精华霜和精华液先用哪个| 在线观看美女被高潮喷水网站 | 在线播放国产精品三级| 一级毛片女人18水好多| 精品久久久久久久人妻蜜臀av| 色老头精品视频在线观看| 国产午夜福利久久久久久| 国产三级在线视频| 香蕉av资源在线| 91久久精品国产一区二区成人 | 久久天躁狠狠躁夜夜2o2o| 国产单亲对白刺激| 人人妻人人看人人澡| 亚洲一区二区三区色噜噜| 一进一出好大好爽视频| 99国产精品一区二区蜜桃av| 性欧美人与动物交配| 色综合婷婷激情| 18禁观看日本| 国产成人精品无人区| 超碰成人久久| 亚洲电影在线观看av| 国产男靠女视频免费网站| 免费av毛片视频| 51午夜福利影视在线观看| 91在线精品国自产拍蜜月 | 在线观看美女被高潮喷水网站 | 动漫黄色视频在线观看| 男女做爰动态图高潮gif福利片| 国产高清有码在线观看视频| x7x7x7水蜜桃| 精品久久久久久久人妻蜜臀av| 免费在线观看影片大全网站| 久久这里只有精品中国| 日本a在线网址| 桃色一区二区三区在线观看| 香蕉久久夜色| 日韩成人在线观看一区二区三区| 黄色视频,在线免费观看| 1024手机看黄色片| 国产在线精品亚洲第一网站| 99精品在免费线老司机午夜| 特级一级黄色大片| 搡老岳熟女国产| 国产私拍福利视频在线观看| 18禁美女被吸乳视频| 精品熟女少妇八av免费久了| 两个人看的免费小视频| 免费在线观看视频国产中文字幕亚洲| 午夜两性在线视频| 国产伦精品一区二区三区视频9 | 国产精品久久久人人做人人爽| 男女视频在线观看网站免费| 中出人妻视频一区二区| 特级一级黄色大片| 精品久久久久久,| 露出奶头的视频| 麻豆国产av国片精品| 怎么达到女性高潮| av在线蜜桃| 国产精品久久久久久精品电影| 麻豆国产av国片精品| 亚洲va日本ⅴa欧美va伊人久久| 亚洲精品色激情综合| aaaaa片日本免费| 三级男女做爰猛烈吃奶摸视频| 亚洲精品国产精品久久久不卡| 成熟少妇高潮喷水视频| 午夜福利在线在线| 午夜福利欧美成人| 岛国在线免费视频观看| 丁香六月欧美| 久久久久久久久久黄片| 亚洲精品乱码久久久v下载方式 | 成在线人永久免费视频| 丰满人妻熟妇乱又伦精品不卡| 97碰自拍视频| 免费看十八禁软件| 一级毛片女人18水好多| 欧美日韩瑟瑟在线播放| 午夜激情福利司机影院| 日韩欧美在线二视频| 少妇的逼水好多| 国产爱豆传媒在线观看| 九色成人免费人妻av| 精品无人区乱码1区二区| 中文资源天堂在线| 精品久久久久久,| 99国产综合亚洲精品| 1024手机看黄色片| 亚洲av电影不卡..在线观看| 男女那种视频在线观看| 国产亚洲精品综合一区在线观看| 久久欧美精品欧美久久欧美| 亚洲性夜色夜夜综合| 亚洲欧美精品综合久久99| 色老头精品视频在线观看| 男女做爰动态图高潮gif福利片| 嫩草影院入口| 精品久久蜜臀av无| 99热这里只有是精品50| 好看av亚洲va欧美ⅴa在| 国语自产精品视频在线第100页| 成人av一区二区三区在线看| 五月伊人婷婷丁香| 日韩高清综合在线| 国产av一区在线观看免费| 久久久久国产精品人妻aⅴ院| 非洲黑人性xxxx精品又粗又长| 亚洲九九香蕉| 国产精品香港三级国产av潘金莲| 日韩精品青青久久久久久| 欧美三级亚洲精品| 成年版毛片免费区| 中文资源天堂在线| 精品国内亚洲2022精品成人| svipshipincom国产片| 免费在线观看亚洲国产| 香蕉国产在线看| 夜夜爽天天搞| 免费大片18禁| 久久香蕉国产精品| 国产精品一及| 国产一区在线观看成人免费| 一区二区三区高清视频在线| 国产精品98久久久久久宅男小说| 色综合婷婷激情| 啦啦啦观看免费观看视频高清| 欧美日韩亚洲国产一区二区在线观看| 99久久国产精品久久久| 男插女下体视频免费在线播放| 岛国在线免费视频观看| 久久久精品欧美日韩精品| 国产av不卡久久| 18禁国产床啪视频网站| 少妇丰满av| 亚洲成人中文字幕在线播放| 人人妻,人人澡人人爽秒播| 色哟哟哟哟哟哟| 熟女电影av网| 国语自产精品视频在线第100页| 国产午夜精品论理片| 国产伦精品一区二区三区四那| 天堂影院成人在线观看| 午夜福利成人在线免费观看| 性欧美人与动物交配| 国内精品久久久久久久电影| 久9热在线精品视频| 久久久久国内视频| 国产成人精品久久二区二区91| 叶爱在线成人免费视频播放| 久久久久久国产a免费观看| 亚洲精品色激情综合| 18禁国产床啪视频网站| 久久婷婷人人爽人人干人人爱| 精华霜和精华液先用哪个| 国产野战对白在线观看| 欧美又色又爽又黄视频| 国产爱豆传媒在线观看| 成人av一区二区三区在线看| 亚洲精品在线美女| 在线a可以看的网站| 一个人看的www免费观看视频| 亚洲va日本ⅴa欧美va伊人久久| 欧美日韩国产亚洲二区| 中文字幕高清在线视频| 国产精品野战在线观看| 国内精品久久久久精免费| 亚洲在线观看片| 欧美一级a爱片免费观看看| 九色国产91popny在线| 一本精品99久久精品77| 在线播放国产精品三级| 高清在线国产一区| 亚洲18禁久久av| 毛片女人毛片| 国产亚洲精品一区二区www| 欧美乱码精品一区二区三区| 可以在线观看毛片的网站| 精品国内亚洲2022精品成人| 一级毛片女人18水好多| 99热精品在线国产| 麻豆一二三区av精品| 亚洲av成人一区二区三| 中文资源天堂在线| 国产成+人综合+亚洲专区| 特级一级黄色大片| 欧美激情久久久久久爽电影| 亚洲av五月六月丁香网| av天堂中文字幕网| 亚洲 欧美 日韩 在线 免费| 动漫黄色视频在线观看| 每晚都被弄得嗷嗷叫到高潮| 麻豆久久精品国产亚洲av| 1000部很黄的大片| 又粗又爽又猛毛片免费看| 婷婷精品国产亚洲av在线| 亚洲成人精品中文字幕电影| 国产真人三级小视频在线观看| 在线观看一区二区三区| 久久精品国产清高在天天线| 亚洲熟妇中文字幕五十中出| 国产三级黄色录像| av在线天堂中文字幕| 黄色丝袜av网址大全| 亚洲乱码一区二区免费版| 两性夫妻黄色片| 一级毛片女人18水好多| 色综合婷婷激情| 在线十欧美十亚洲十日本专区| 色老头精品视频在线观看| 女同久久另类99精品国产91| 身体一侧抽搐| 欧美+亚洲+日韩+国产| 天天躁狠狠躁夜夜躁狠狠躁| 色噜噜av男人的天堂激情| 国产精品久久久久久精品电影| 美女高潮喷水抽搐中文字幕| 天堂√8在线中文| 舔av片在线| 国产成人精品无人区| 99久国产av精品| 我的老师免费观看完整版| 日日干狠狠操夜夜爽| 色综合欧美亚洲国产小说| 日韩精品中文字幕看吧| 亚洲自拍偷在线| 一个人免费在线观看电影 | h日本视频在线播放| 巨乳人妻的诱惑在线观看| 天堂动漫精品| 亚洲av第一区精品v没综合| 美女cb高潮喷水在线观看 | 熟女电影av网| 午夜福利在线在线| 久久久成人免费电影| 亚洲精品国产精品久久久不卡| 国产黄色小视频在线观看| 桃红色精品国产亚洲av| 久久久久性生活片| 黄色丝袜av网址大全| 中文字幕高清在线视频| 老熟妇乱子伦视频在线观看| 999久久久精品免费观看国产| 狠狠狠狠99中文字幕| 日日夜夜操网爽| 欧美在线黄色| 夜夜爽天天搞| 国产又黄又爽又无遮挡在线| 精品一区二区三区视频在线观看免费| 色吧在线观看| 久久九九热精品免费| 国产探花在线观看一区二区| 亚洲成人久久性| 波多野结衣高清作品| 日韩av在线大香蕉| 非洲黑人性xxxx精品又粗又长| 国产成+人综合+亚洲专区| 亚洲精品在线美女| 成人三级黄色视频| 久久精品影院6| 一个人观看的视频www高清免费观看 | 日韩欧美国产一区二区入口| 久久亚洲精品不卡| or卡值多少钱| 毛片女人毛片| 国产激情久久老熟女| 国产成人精品久久二区二区免费| 亚洲欧美精品综合一区二区三区| av天堂在线播放| 国产高清视频在线观看网站| 两个人视频免费观看高清| 久久久国产成人免费| 亚洲男人的天堂狠狠| 久久久久久久久中文| 一区二区三区激情视频| av国产免费在线观看| 国产三级黄色录像| 性色avwww在线观看| 欧美一级毛片孕妇| 小蜜桃在线观看免费完整版高清| 99视频精品全部免费 在线 | 两性夫妻黄色片| 99热这里只有精品一区 | 亚洲自偷自拍图片 自拍| 精品国产亚洲在线| 亚洲片人在线观看| 久久中文字幕人妻熟女| 国产淫片久久久久久久久 | xxx96com| 免费av不卡在线播放| 97人妻精品一区二区三区麻豆| 国产一区二区激情短视频| 俺也久久电影网| 亚洲国产中文字幕在线视频| 搡老熟女国产l中国老女人| 午夜视频精品福利| 国产私拍福利视频在线观看| 亚洲欧美日韩卡通动漫| xxxwww97欧美| 一级毛片高清免费大全| 999精品在线视频| 亚洲激情在线av| 亚洲国产欧美一区二区综合| 亚洲第一欧美日韩一区二区三区| 中文字幕人成人乱码亚洲影| 亚洲精品国产精品久久久不卡| 亚洲精品久久国产高清桃花| 精品99又大又爽又粗少妇毛片 | 成年女人毛片免费观看观看9| 久久久久久久久中文| 国产爱豆传媒在线观看| www.999成人在线观看| 欧美成人一区二区免费高清观看 | 人妻夜夜爽99麻豆av| 亚洲,欧美精品.| 欧美成人一区二区免费高清观看 | 久久久久久九九精品二区国产| 亚洲熟妇中文字幕五十中出| 黄片大片在线免费观看| 亚洲天堂国产精品一区在线| av福利片在线观看| 美女午夜性视频免费| 性色av乱码一区二区三区2| e午夜精品久久久久久久| 欧美高清成人免费视频www| 国产三级中文精品| 久久久国产精品麻豆| 熟女人妻精品中文字幕| 日日夜夜操网爽| 一进一出抽搐gif免费好疼| 一二三四社区在线视频社区8| 毛片女人毛片| 高潮久久久久久久久久久不卡| 国产一区二区三区视频了| 国产精品一区二区三区四区久久| 性色avwww在线观看| 最近最新中文字幕大全电影3| 在线a可以看的网站| 国产精品,欧美在线| 俺也久久电影网| 国产成人av激情在线播放| 色哟哟哟哟哟哟| 国产午夜精品久久久久久| 熟女人妻精品中文字幕| 久久久久久久久中文| 亚洲精品一区av在线观看| 制服丝袜大香蕉在线| 色综合欧美亚洲国产小说| 免费无遮挡裸体视频| 他把我摸到了高潮在线观看| a在线观看视频网站| 高潮久久久久久久久久久不卡| 成人av一区二区三区在线看| 国产成人福利小说| 中文字幕精品亚洲无线码一区| 在线观看舔阴道视频| 丁香欧美五月| 男女视频在线观看网站免费| av黄色大香蕉| 黄色 视频免费看| a级毛片a级免费在线| e午夜精品久久久久久久| 欧美精品啪啪一区二区三区| 久久这里只有精品中国| 禁无遮挡网站| 99国产精品99久久久久| 村上凉子中文字幕在线| 女警被强在线播放| 久久久久久人人人人人| 久久久色成人| 黄色成人免费大全| 欧美日韩乱码在线| 脱女人内裤的视频| 国产精品av视频在线免费观看| 久久久久性生活片| 麻豆久久精品国产亚洲av| 亚洲精华国产精华精| 色综合婷婷激情| 久久精品夜夜夜夜夜久久蜜豆| 成年人黄色毛片网站| 中文资源天堂在线| 久久婷婷人人爽人人干人人爱| 后天国语完整版免费观看| 亚洲成av人片在线播放无| avwww免费| 在线观看日韩欧美| 亚洲最大成人中文| 国产精品免费一区二区三区在线| 欧美日韩一级在线毛片| 韩国av一区二区三区四区| 99久久精品热视频| 熟女人妻精品中文字幕| 亚洲va日本ⅴa欧美va伊人久久| 宅男免费午夜| 欧美色欧美亚洲另类二区| 国产精品98久久久久久宅男小说| 久久精品影院6| 精品午夜福利视频在线观看一区| 国产三级在线视频| 成年免费大片在线观看| 97碰自拍视频| 精品免费久久久久久久清纯| 国产亚洲精品av在线| 国产亚洲欧美在线一区二区| 久久国产精品人妻蜜桃| 热99在线观看视频| 女人被狂操c到高潮| 午夜免费成人在线视频| 女警被强在线播放| 每晚都被弄得嗷嗷叫到高潮| 欧美乱妇无乱码| 亚洲无线观看免费| 国产欧美日韩精品亚洲av| 午夜福利成人在线免费观看| 久久久久久九九精品二区国产| 亚洲黑人精品在线| 看黄色毛片网站| 国产91精品成人一区二区三区| 亚洲成a人片在线一区二区| 日韩中文字幕欧美一区二区| 偷拍熟女少妇极品色| 午夜精品一区二区三区免费看| 五月伊人婷婷丁香| 亚洲人与动物交配视频| 精品不卡国产一区二区三区| 亚洲九九香蕉| 精品国内亚洲2022精品成人| 亚洲美女视频黄频| e午夜精品久久久久久久| 国产午夜福利久久久久久| 最近最新中文字幕大全免费视频| 丁香六月欧美| 国产私拍福利视频在线观看| 久久精品国产99精品国产亚洲性色| 精品不卡国产一区二区三区| 哪里可以看免费的av片| e午夜精品久久久久久久| 亚洲精品一卡2卡三卡4卡5卡| 国产精品九九99| 中文字幕最新亚洲高清| 日韩欧美国产一区二区入口| www.www免费av| 少妇熟女aⅴ在线视频| 亚洲国产欧美人成| 亚洲人成网站高清观看| 热99在线观看视频| 性欧美人与动物交配| 又粗又爽又猛毛片免费看| 毛片女人毛片| 亚洲欧美精品综合一区二区三区| 香蕉丝袜av| 少妇的逼水好多| АⅤ资源中文在线天堂| svipshipincom国产片| 亚洲成人中文字幕在线播放| 99riav亚洲国产免费| 免费观看精品视频网站| 一进一出好大好爽视频| 午夜激情福利司机影院| 亚洲欧美日韩东京热| 中文字幕熟女人妻在线| 丁香六月欧美| www.999成人在线观看| 中文字幕最新亚洲高清| 亚洲片人在线观看| 久久久久国产一级毛片高清牌| av天堂在线播放| 18禁黄网站禁片午夜丰满| 人妻夜夜爽99麻豆av| 美女cb高潮喷水在线观看 | 亚洲中文av在线| 精品国内亚洲2022精品成人| 欧美黑人欧美精品刺激|